YR
Yasmeen Rahimi Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
22
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $25 |
228%
upside
| 1 | -7.1% |
0
%
| 4 Mar ‘26 7 hours ago |
|
|
|
Overweight
Initiated
| $23 |
223%
upside
| 1 | +32% |
0
%
| 13 Feb ‘26 19 days ago |
|
|
|
Overweight
Upgraded
| $30 |
168%
upside
| 1 | -6.5% |
0
%
| 29 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $1,200 |
267%
upside
| 1 | +3.6% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $15 |
230%
upside
| 1 | +7.5% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $73 |
250%
upside
| 1 | +13% |
0
%
| 27 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $25 |
1,337%
upside
| 1 | -21% |
0
%
| 29 Dec ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $900 |
106%
upside
| 1 | +2% |
0
%
| 19 Dec ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $75 |
117%
upside
| 1 | -5.3% |
0
%
| 18 Dec ‘25 2 months ago |
|